- Home
- LOAN vs BEAT Comparison
LOAN vs BEAT Comparison
Compare LOAN & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOAN | BEAT |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 44.8M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | LOAN | BEAT |
|---|---|---|
| Price | $4.28 | $0.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 26.0K | ★ 1.4M |
| Earning Date | 04-16-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $8,666,307.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | $38.45 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.13 | $0.54 |
| 52 Week High | $5.85 | $4.00 |
Technical Indicators
Market Signals| Indicator | LOAN | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 41.46 |
| Support Level | $4.26 | $0.80 |
| Resistance Level | $4.45 | $1.26 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 20.82 | 60.93 |
Price Performance
Historical ComparisonAbout LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.